We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Versarien Plc | LSE:VRS | London | Ordinary Share | GB00B8YZTJ80 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.002 | -6.06% | 0.031 | 0.031 | 0.0338 | 0.0338 | 0.03 | 0.033 | 27,560,582 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 5.45M | -13.53M | -0.0058 | -0.05 | 770.33k |
30 September 2024
Versarien plc
("Versarien" or the "Company" or the "Group")
Disposal of AAC Cyroma Limited
Versarien plc (AIM: VRS), the advanced materials engineering group, announces that, in line with the Company's stated strategy, it has completed a binding agreement for the sale of the Company's wholly owned subsidiary, AAC Cyroma Limited ("AAC Cyroma"), to Harper Bennett Limited for a total consideration of £550,000, subject to any adjustments arising from completion accounts.
The consideration of £550,000 is payable in cash, in 16 equal quarterly instalments of £34,375, commencing three months from completion. Versarien will retain a charge over the assets of AAC Cyroma and Harper Bennett Limited to cover any outstanding consideration payable.
AAC Cyroma is a specialist plastics manufacturing business serving a range of sectors including automotive and fast-moving consumer goods. In the financial year ended 30 September 2023 AAC Cyroma incurred a loss of £146,350 and had net assets at 30 September 2023 of £411,142. The disposal of AAC Cyroma is in line with the Company's strategy to focus on its core graphene technology and divesting of its mature businesses. The proceeds of the disposal will be used for the Company's general corporate and working capital purposes.
Stephen Hodge, Chief Executive Officer of Versarien, commented: "The sale of AAC Cyroma is a pivotal step in our turnaround strategy, allowing the Company to continue to focus on maximising the potential from graphene and advanced engineering technologies, and take a manufacturing-light approach. In our core business the pipeline of opportunities and partnerships continues to improve and I believe that Versarien is increasingly well positioned for sustained growth and industry leadership."
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
For further information please contact:
Versarien Stephen Hodge, Chief Executive Officer Chris Leigh, Chief Financial Officer |
c/o IFC |
|
|
SP Angel Corporate Finance (Nominated Adviser and Broker) Matthew Johnson, Adam Cowl |
+44 (0)20 3470 0470
|
|
|
IFC Advisory Limited (Financial PR and Investor Relations) Tim Metcalfe, Zach Cohen |
+44 (0) 20 3934 6630 |
About Versarien:
The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a manufacturing-light and licensing model.
For further information please see: http://www.versarien.com
1 Year Versarien Chart |
1 Month Versarien Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions